ArticleImmunoHorizons2026
Expression of ultralong complementarity determining region 3 and development of IgM and IgG B cell receptor repertoires in Holstein heifer calves.
Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
There are currently knowledge gaps regarding the development of the bovine B cell repertoire especially for cells expressing B cell receptors with heavy chain ultralong complementarity determining region 3 (CDR3). The objective of this study was to assess percentages of B cells with ultralong CDR3s, and immunoglobulin heavy chain gene usage in Holstein calves from birth to 10 mo of age. Blood was collected from 7 heifer calves on the following days of life: 0 (prior to ingestion of colostrum), 2 (after colostrum ingestion), 42, 56, 90, and 285. IgM+ and IgG+ B cells were collected using magnetic-bead separation. RNA was extracted, cDNA was produced, and IgM and IgG sequences were amplified using polymerase chain reactions. Amplicons were sequenced using long-read Oxford Nanopore sequencing on R10.4 flow cells. Differences in the percentages of B cells with ultralong CDR3s were assessed using non-parametric Wilcoxon signed-rank tests. The mean percentage of productive IgM ultralong CDR3 sequences at birth was 3.27%, which decreased by day 42 and remained low until there was a significant increase between day 90 and ∼day 285 (5.68% ± 1.51 standard error of the mean, P = 0.03). The mean percentage of productive IgG ultralong CDR3 sequences was low at birth (0.89%) and remained low until there was a significant increase between day 90 and ∼day 285 (6.86% ± 0.99, P = 0.03). These increases in the percentages of sequences with ultralong CDR3 may be indicative of increased antigenic exposure and concurrent maturation of immune functionality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.